Investors

Webcast ImageClick here for Webcast
Xtant Medical Holdings Inc at the LD Micro Conference (Replay)
06/08/16 at 10:30 a.m. PT
Xtant Medical Holdings Inc at the LD Micro Conference
Wednesday, June 8, 2016 10:30 a.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Xtant Medical Holdings, Inc. (NYSE MKT: XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and...
More

Stock Quote
XTNT (Common Stock)
Price$2.00
Change (%) - 0.05 (2.44%)
Volume4,470
Data as of 06/24/16 3:59 p.m. ET
Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.

Stock Chart
Stock chart for: XTNT.K.  Currently trading at $2.00 with a 52 week high of $4.49 and a 52 week low of $1.51.
Recent News
DateTitle 
06/16/16Xtant™ Medical Announces Changes to Its Executive Management and Board of Directors
BELGRADE, Mont., June 16, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced the appointment of Paul Buckman, Eric Timko, and Rudy Mazzocchi to its Board of Directors.  The Company also announced the resignation of Directors Jon Wickwire and David Goodman.  The above changes will be effective as of July 2, 2016. Paul Buckman has more than 30 years of experience as a busines... 
06/08/16Xtant Medical and Pinnacle Spine Group Announce Distribution Agreement, Expanding the Availability of Innovative InFill® Lateral Fusion System
BELGRADE, Mont. and DALLAS, June 08, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices and Pinnacle Spine Group, LLC, a developer of innovative spinal fusion solutions, today announced a joint agreement to expand distribution of Pinnacle's InFill® Lateral Lumbar Interbody Fusion System. Through this agreement, Xtant enters the lateral lumbar interbody fusion market, expanding its spinal hardw... 
05/26/16Xtant Medical Completes New Accounts Receivable Revolver Credit Facility with Silicon Valley Bank
New facility provides additional working capital to continue Company market expansion plans BELGRADE, Mont., May 26, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today announced the completion of an accounts receivable revolver credit facility with Silicon Valley Bank to provide up to $6 million in funds to the Company. Dan Goldberger, Chief Ex... 
05/17/16Xtant Medical to Present at Investor Conferences
BELGRADE, Mont., May 17, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), formerly Bacterin International Holdings, Inc., a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today announced that its Chief Executive Officer, Dan Goldberger will be presenting at the following conferences: 17th Annual B. Riley & Co. Investor Conference The Company will be presenting at the 17th Annual B. Riley &... 
More

Upcoming Events
There are currently no events scheduled.
More

Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Xtant Medical Holdings Inc posts new information to the site. Just enter your e-mail address and click Submit.